Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.
about
Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for TrachomaAntibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trialCommunity based interventions for the prevention and control of Non-Helmintic NTDImpact of intermittent preventive treatment in pregnancy with azithromycin-containing regimens on maternal nasopharyngeal carriage and antibiotic sensitivity of Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus: a cross-secAzithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children.Topical ocular antibiotics induce bacterial resistance at extraocular sites.Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.Epidemiology and control of trachoma: systematic review.Azithromycin, fluoroquinolone and chloramphenicol resistance of non-chlamydia conjunctival bacteria in rural community of Ethiopia.Intermittent preventive treatment against malaria: an update.Trachoma and antibiotic use: the 'A' in SAFE.Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics.Two regimens of azithromycin prophylaxis against community-acquired respiratory and skin/soft-tissue infections among military trainees.
P2860
Q26777935-2CD10D71-45E9-4A05-A6A1-F4E7EF5E021EQ28476520-8C577421-0D89-4B6D-9358-F9703B7EBF89Q28656181-40F0D8CF-16B1-4D71-8F4C-DF3763204302Q35193325-679D622B-2797-4547-84FD-CA8584D9CF50Q35205935-D94D6606-92D5-44FA-948D-694AFA55BE13Q35246081-0B1C1824-6EA8-47A8-BB0D-B2128424F9F3Q35593627-35228967-ED2D-4964-BD6C-B967A6B23364Q36325816-57D32ABF-FB04-46C1-8736-76A5BB6F32D2Q37076814-2C5E957A-24CB-4363-B589-D1AB7657907CQ37165258-D44710F2-9392-4F16-A876-9654A771D3D4Q37733458-F0F06FAC-69DB-4B18-9CBC-3E0C1B574D3AQ37747411-82C61407-8ED2-4FE6-B352-7322743F4F6EQ37849704-052BAFB3-4648-4F2E-BF34-F54C076BD7ACQ37899268-77ECB95B-58A3-4C53-A3DF-E06C7132D45FQ44850122-D6E88097-C9D4-427A-B14D-A9387773B701
P2860
Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Community treatment with azith ...... tococcus pneumoniae at 1 year.
@ast
Community treatment with azith ...... tococcus pneumoniae at 1 year.
@en
type
label
Community treatment with azith ...... tococcus pneumoniae at 1 year.
@ast
Community treatment with azith ...... tococcus pneumoniae at 1 year.
@en
prefLabel
Community treatment with azith ...... tococcus pneumoniae at 1 year.
@ast
Community treatment with azith ...... tococcus pneumoniae at 1 year.
@en
P2093
P2860
P356
P1476
Community treatment with azith ...... tococcus pneumoniae at 1 year.
@en
P2093
B D Gaynor
J P Whitcher
J S P Chaudhary
K A Holbrook
R C Bhatta
P2860
P304
P356
10.1136/BJO.87.2.147
P407
P577
2003-02-01T00:00:00Z